CEFAS approval has been a drawn out process as stated in company announcements. As far as we know to date there has not been any rejection in the testing. Should this occur however whether that even be some form of major setback, then l would expect the company to provide an update of such as it relates to a material transaction.
Ann: Annual Financial Report 2022, page-56
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add HCD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.425M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 12000000 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 900000 | 1 |
View Market Depth
| Last trade - 16.12pm 16/10/2024 (20 minute delay) ? |
| HCD (ASX) Chart |
Day chart unavailable